Vetstream header image and menu Click for a free trial
Liver function assessment
Feedback
Introduction Top

  • Accurate clinical evaluation of liver function can be accomplished by a series of diagnostic procedures.
  • Physical examination and a complete history of the patient are important in the diagnosis of liver failure - most signs are relatively non-specific.
    Tip Important in differentiating acute from chronic disease.
  • Therefore, examination of urine and blood samples is essential in the diagnostic process.
  • Tests can be divided into two categories, ie those indicating hepatocellular damage and those measuring hepatic function.
  • This approach is a guide to the investigation of liver disease and, although examples of tests are quoted, the lists are by no means complete.
  • Remember both primary liver disease (cirrhosis Liver: cirrhosis , toxic hepatitis Liver: toxic hepatitis ) occur as does secondary disorders (Cushing's disease, heart disease).
Is it likely that the patient has liver disease?
    Signalment
      Age
      • Young: increased likelihood of congenital disease, eg portosystemic shunt (PSS) Portosystemic shunt.
      • Adult: most likely to be inflammatory or infectious disease. Consider toxic insult Ethylene glycol poisoning , or drug damage, eg steroid hepatopathy.
      • Geriatric: may have chronic degenerative changes, eg cirrhosis Liver: cirrhosis.
      Breed
      • Some breeds have congenital/familial liver disease, eg PSS Portosystemic shunt in Yorkshire Terrier, Irish Wolfhound and others; or copper toxicosis in Bedlington Terrier Bedlington Terrier , Doberman Pinscher Dobermann , West Highland White Terrier West Highland White Terrier.
      • Chronic active hepatitis Chronic hepatitis also predominantly affects some breeds, eg Doberman Pinscher and others.
      Clinical signs
      • Depression.
      • Polyuria/polydipsia.
      • Weight loss.
      • Nausea, eg inappetence/anorexia, lip smacking, excessive salivation.
      • Vomiting or diarrhea.
      • Pacing, hyperexcitability, seizures (hepatic encephalopathy in advanced liver failure).
      • Icterus.
      • Ascites.
      • Acholic feces.
      • Intolerance to sedation and anesthesia.
      • Gastrointestinal ulceration.
      • Hepatocutaneous syndrome.
      • Coagulopathies.
      Clinical examination
      • Palpation of liver size and shape:
        • Small liver may indicate cirrhosis or PSS.
        • Large liver may indicate acute inflammation Glomerulonephritis , amyloidosis Amyloidosis , hypertrophy or infiltration, extramedullary hematopoiesis, passive congestion or neoplasia Liver: neoplasia.
        • Hepatic pain is associated with acute inflammation.
      Laboratory investigation Top

      • Where history and clinical signs are suggestive of liver disease, or in a particular breed with a predisposition to congenital liver disease, or a general health screen suggests liver involvement, further evaluation of liver function is necessary.
      • Try to answer the following questions:
        • Is there evidence of liver damage?
        • Is the damage affecting primarily the hepatocellular or biliary system?
        • Is there evidence of liver dysfunction?
        • What is the prognosis?
        • Is there evidence of liver failure?
        • Do the laboratory screening tests support hepatic involvement?

      Ascitic fluid analysis

      • If ascitic fluid is present a sample should be collected for analysis.
      • True transudate associated with failure to produce albumin.
      • Modified transudate associated with portal hypertension.

      Blood sample analysis

      Serum protein

      • Liver is important for synthesis of albumin Blood biochemistry: albumin and globulins Blood biochemistry: total globulin.
      • In severe hepatic disease synthesis of these is reduced and hypoproteinemia Hypoproteinemia as a result of hypoalbuminemia or occasionally hypoglobulinemia (or both) may result.
        Tip In fact, in most cases of severe liver disease hypergammaglobulinemia is present.
      • In inflammatory conditions, protein production in the liver switches from albumin to acute phase proteins and this can cause a transient decrease in albumin concentrations.
      • This hypoproteinemia may contribute to ascites in cases with portal hypertension.

      Ammonia

      • Ammonia absorbed from the gut is detoxified in the liver.
      • Increasing ammonia Blood biochemistry: ammonia concentrations in peripheral circulation can result in signs of hepatic encephalopathy Hepatic encephalopathy.
      • Ammonia is difficult to measure accurately in blood as it is volatile and analysis must be done soon after sampling.

      Urea

      • Urea is synthesized in the liver as a method of detoxifying ammonia absorbed from the gut.
      • In severe liver disease urea Blood biochemistry: urea concentrations may be reduced.
        Do not rely on low urea levels to indicate liver dysfunction - it is not specific.

      Glucose

      • Glycogen is synthesized in the liver as a storage mechanism for glucose and, in prolonged starvation, the liver is the main site of gluconeogenesis.
      • In severe liver failure hypoglycemia Hypoglycemia may develop.

      Is the liver involvement primary or secondary?

      • Many diseases can cause secondary hepatic changes:
        • Steroid hepatopathy (or simply hepatomegaly and sALP increase) in hyperadrenocorticism Hyperadrenocorticism.
        • Hepatic hypoxia due to poor perfusion in severe cardiac disease.
        • Hepatomegaly and damage due to right sided heart failure and hepatic congestion.
      Is the damage affecting the hepatocytes or biliary system? Top



      Assessment of hepatocellular damage
      • Hepatocyte damage is assessed by measurement of enzymes released from damaged hepatocytes:
        • Alanine aminotransferase (ALT) Blood biochemistry: alanine aminotransferase (SGPT ALT).
        • Aspartate aminotransferase (AST) Blood biochemistry: aspartate aminotransferase (AST).
      • These enzymes are only released while damage is ongoing.
      • These enzymes are not liver function tests.
      • Animals with fibrotic livers may have severly impaired liver function but no active cellular destruction. Therefore, liver enzymes may be normal.

      Alanine aminotransferase (ALT)

      • ALT Blood biochemistry: alanine aminotransferase (SGPT ALT) is found within the cytoplasm of hepatocytes.
      • After a one-off insult, levels peak in 3-4 h and return to normal in 14 days.
      • If levels remain high ongoing damage is likely.
      • Elevations in ALT crudely correlate with numbers of hepatocytes damaged.

      Aspartate aminotransferase (AST)

      • AST Blood biochemistry: aspartate aminotransferase (AST) is found in many cells.
      • Not specific for liver damage so elevated levels may be seen in other diseases.
      • The elevation of AST crudely correlates with hepatocyte damage.

      Assessment of biliary damage

      • Cholestasis is the stagnation of bile flow and can be caused by intra- or extra-hepatic factors.

      Alkaline phosphatase (ALP)

      • Serum ALP Blood biochemistry: alkaline phosphatase (ALP) is a good indicator of cholestasis as it is readily released from bile duct before plasma bilirubin elevated.
      • Lag between injury and rise in ALP of 2-3 days.
      • Takes 10 days to return to normal after insult.
      • ALP may also elevate following use of steroids, Cushing's disease and in young growing animals.

      Gamma glutamyltransferase (GGT)

      • GGT Blood biochemistry: gamma glutamyltransferase is found on surface of hepatocytes and bile duct epithelium.
      • GGT has a longer half-life than ALP.
      • Elevations seen in hepatocellular damage and biliary disease.

      Cholesterol

      • The liver is the site of cholesterol regulation.
      • Cholesterol Blood biochemistry: cholesterol concentrations may be reduced in severe hepatic failure and portosystemic shunts.
      • Biliary disease may result in increased cholesterol concentrations due to reflux from bile into blood and increased synthesis.

      Assessment of hepatic function

      Bilirubin

      • Hyperbilirubinemia is associated with bile duct obstruction and liver disease.
        Remember in hemolysis the liver's ability to conjugate bilirubin may be overwhelmed and icterus can develop without liver dysfunction.
      • Low levels of bilirubin (1+ on a dipstick) in the urine of a dog can be normal.
      • Bilirubinuria of 2+ or 3+ is an indication of hyperbilirubinemia.

      Do not use the ratio of congugated to uncongugated bilirubin to differentiate liver disease from cholestasis.

      Bile acid stimulation test

      • Bile acids Blood biochemistry: bile acids are synthesized in the liver and released through the bile ducts to the intestine and then taken up in the portal circulation and recycled.
      • They should not appear in the circulation in significant concentrations.
      • Sensitive indicators of hepatic function and biliary and portal circulation.
      • Elevations in a fasted serum sample indicate abnormal liver function.
      • The stimulation test is performed by measuring peripheral blood concentration pre- and post-prandially - rising bile acids is a more sensitive indiction of abnormal hepatic function.

      Scintigraphy

      • Primarily used in the investigation of portosystemic shunts Scintigraphy: hepatic for PSS.
      • Can also give indication of hepatic function Scintigraphy: hepatic function.
      • Radioactive material put into intestine and liver uptake monitored.

      Clotting parameters

      • Liver has important role in synthesis of particular clotting factors.
      • Spontaneous bleeding is rare in animals with liver disease.
        Tip Clotting parameters should always be checked prior to biopsy.
      • Prolonged activated partial thromboplastin time (APPT) Hematology: activated partial thromboplastin time.
      • Prolonged prothrombin time (PT) Hematology: prothrombin time.
      • Both indicative of severe hepatic dysfunction.
      • Platelet dysfunction may also occur in liver disease.

      BSP clearance

      • Now superceded by more modern tests.
      Imaging Top



      Radiography
      • Useful to determine size of liver:
        • Small Prostate: prostatomegaly - radiograph lateral suggests chronic liver failure.
        • Large suggests neoplasia Liver: neoplasia , acute inflammation.
      • The shape of the liver may give a clue to the etiology of the disease:
        • Generalized enlargement Liver: hepatomegaly (Cushings disease) - radiograph lateral indicates diffuse infiltrative disease.
        • Focal enlargement Abdomen: hepatomegaly (tumor) - lateral radiograph may be seen with lobar neoplasia or cysts.

      Hepatoportal angiography

      • Invasive as requires general anesthesia but allows good visualization of portal vein abnormalities.
      • Largely been superceded by hepatic ultrasonography.

      Ultrasonography

      • Used to examine liver architecture Ultrasonography: liver.
      • This is an essential modality in the presence of ascitic fluid.
      • Ultrasound can be used to guide biopsy and, since the type of lesion cannot be differentiated by the use of ultrasound alone, it is essential to perform a biopsy if lesions are visible ultrasonographically.
      • May also be used to detect presence of portosystemic shunts.

      Fine needle aspirate (FNA)

      • FNA Fine-needle aspirate can be used to collect a tissue sample for cytological examination.
      • This is most useful in cases of diffuse disease or in conjunction with ultrasound guidance where the chance of obtaining a representative sample is greater.
      • Rarely provides a definitive diagnosis.

      Liver biopsy

      • May provide information about pathogenesis of disease and etiology, except in cases of 'end stage' liver failure.
      • Can be performed percutaneously Hepatic biopsy (usually with ultrasound guidance) and a biopsy gun technique.
      • Surgical biopsy allows visualization of the whole organ and careful sample site selection which may improve diagnostic success.

      Prognostic indicators

      • Many authors have looked for prognostic indicators in liver disease.
      • The most reliable seem to be acute phase protein concentrations:
        • Reduced albumin and alpha-globulin gives poor prognosis.
        • Reduced albumin, normal alpha-1 antitrypsin and slight increase in hepatoglobin indicates chronic progressive hepatitis.
        • Acute hepatitis is characterized by acute phase increase in alpha-globulins.
      Sources Top

      Publications
      Refereed papers
      • Recent references from PubMed.
      • Roth L (2001) Comparison of liver cytology and biopsy diagnoses in dogs and cats: 56 cases. Vet Clin Pathol 30 (1), 35-38.
      • Center S (1999) Chronic liver disease: current concepts of disease mechanisms. JSAP 40 , 106-114.

      Other sources of information
      • Center S, Schermerhorn T, Lyman R, Phillips L (2000) Hepatoportal Microvascular Dysplasia. In: Current Veterinary Therapy XIII. Bonagura J (ed), W B Saunders, Philadelphia. pp 682-686.
      • Hess P R & Bunch S E (2000) Diagnostic Approach to Hepatobiliary Disease. In: Current Veterinary Therapy XIII. Bonagura J (ed), W B Saunders, Philadelphia. pp 659-664.


      Vetstream contributor(s)
      • Dr Kyle Braund BVSc MVSc PhD FRCVS DipACVIM , Veterinary Neurological Consulting Services, 1476 Lakeview Ridge, Dadeville, AL 36853, USA.
      • Dr James W Simpson SDA BVM&S MPhil MRCVS , Department of Veterinary Clinical Studies, Royal (Dick) School of Veterinary Studies, Easter Bush Veterinary Hospital, Nr Roslin, Midlothian EH25 9RG, UK.

      Back to top
      © Copyright Vetstream

      CANIS FRE00120

















































































      Subscribers and trialists can view the additional links below and within the adjacent article. To trial our services click here:
      Amyloidosis
      Bedlington Terrier
      Blood biochemistry: alanine aminotransferase (SGPT ALT)
      Blood biochemistry: albumin
      Blood biochemistry: alkaline phosphatase (ALP)
      Blood biochemistry: ammonia
      Blood biochemistry: aspartate aminotransferase (AST)
      Blood biochemistry: bile acids
      Blood biochemistry: cholesterol
      Blood biochemistry: gamma glutamyltransferase
      Blood biochemistry: total globulin
      Blood biochemistry: urea
      Chronic hepatitis (Dobermann)
      Chronic hepatitis
      Dobermann
      Ethylene glycol poisoning
      Fine-needle aspirate
      Glomerulonephritis
      Hematology: activated partial thromboplastin time
      Hematology: prothrombin time
      Hepatic biopsy
      Hepatic encephalopathy
      Hyperadrenocorticism
      Hypoglycemia
      Hypoproteinemia
      Liver: acute disease
      Liver: cirrhosis
      Liver: copper accumulation - West Highland White and Skye Terriers
      Liver: neoplasia
      Liver: toxic hepatitis
      Portosystemic shunt
      Radiology: liver
      Scintigraphy: hepatic for PSS
      Scintigraphy: hepatic function
      Ultrasonography: liver
      West Highland White Terrier
      Abdomen: hepatomegaly (tumor) - lateral radiograph Link Liver: hepatomegaly (Cushings disease) - radiograph lateral Link
      Prostate: prostatomegaly - radiograph lateral Link
      Please click on the links below to view this months other FOC content:
      Click to subscribe
      Copyright © Vetstream  Terms and Conditions  Privacy policy